Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
36 Cards in this Set
- Front
- Back
Naive vs. effector T-cells
|
- Naive have not encountered Ag's
- Effector cells - have seen Ag's, differentiated to helper or cytotoxic |
|
2-signal activation process for naive T-cells
|
- Matching MHC-Ag complex
- Co-stimulatory signal from same APC - CD28 on T-cell sees B7 - This ensures they only get activated by APC's |
|
Professional APC's
|
- Dendritic, Macrophages, B-cells
- All express B7 - can give the co-stimulatory signal |
|
Effect of co-stimulation
|
- Like turning both missile keys
- T-cell becomes activated -> Only needs to see MHC-Ag complex to act |
|
Anergy purpose, mechanism
|
- Negative selection not perfect - keeps auto-immune cells in check
- Unresponsiveness of T-cell resulting from encountering Ag without co-stimulation - Even if sees Ag in APC afterwards, it won't respond! - Die from neglect... |
|
Activated cell IL-2 response
|
- Naive cell has very low level IL-2 receptors
- Activated cells upregulate IL-2 receptors AND IL-2 itself and surrounding cells - Self-stimulated growth! |
|
Effector T-cell types overview
|
- CD8 -> cytotoxic T-cells
- CD4 -> T-reg or Helper T-cells - Variety of helpers for all different pathogens... |
|
Cytotoxic T-cells (CTLs)
|
- Derived from CD8 cells, see MHC I
- Kill virus, tumor, or any other cell presenting foreign peptides via MHC I on surface |
|
2 CTL killing mechanisms
|
1) Direct toxin delivery
- Cytotoxins stored in lytic granules - TCR engagement -> Perforin opens a hole in cell - Granzymes -> cleave caspases -> Apoptosis 2) Fas-FasL pathway - Fas on target cell is stimulated by the FasL on CTL - Stimulates apoptosis |
|
2 methods to avoid killing innocent bystanders
|
1) Activated cells are stimulated by TCR
- Normal cells have nothing to fear 2) CTL's align themselves with target cell when releasing granules - Very precise release of granules |
|
Cathepsin B purpose
|
- Resists perforin and Granzyme B binding to CTL itself!
- Avoids killing itself! |
|
CD4 T-cell differentiation process
|
- Naive CD4 cell activated by APC with MHC II
- Th0 = activated, still undifferentiated, branch point - IL-12 from APC -> Th1 cell -> IFN-γ - Macrophage activation, inflammation - IL-4 from APC -> Th2 cell -> IL-4,5,13 - B-cell switch to IgE - Eosinophil activation - Mast cell stimulation - Mostly for parasites...not much use to us... |
|
Th1 macrophage activation
|
- Resting macrophages are lazy, activated ones -> extremely bactericidal
- IFN-γ and CD40L on Th1 - activate macrophage |
|
Activated macrophage products
|
- Express more CD40 and TNF receptor - more sensitive
- TNF-α - NO - O2- radicals (kill bacteria) - Upregulate MHC I, II, B7 - Activate naive T-cells |
|
Activated Th1 products
|
- IFN-γ and CD40L = activate macrophages to destroy bacteria
- Fas ligand = stuffed macrophages apoptosis - IL-2 - increase number of active effector cells - IL3 - more macrophage differentiation in marrow - TNF-α and β = endothelial opening for macrophage migration - CXCL2 = chemotaxis of macrophages to infected area |
|
Granuloma formation
|
- Poor IFN-γ production
- T-cells can't effectively activate macrophages (or macrophages aren't disposing of bacteria) - T-cells gather around clump of macrophages |
|
Th2 differentiation, products, and action
|
- IL-4 causes Th0 -> Th2
- Th2 produces IL-4,5,13 - IgE switching - Eosinophil, mast cell stimulation *** Macrophage INACTIVATION |
|
Main Th2 activity in the US
|
- Allergic reactions!
- We don't really get worms... |
|
Th17 activation, action
|
- Activated by IL-6, TGF-β
- Makes IL-17 - Neutrophil recruitment and inflammation - Good for bacterial, yeast, fungal *** Can also promote auto-immunity |
|
Th17/IL-17 diseases
|
- Upregulated in multiple sclerosis, arthritis, etc.
|
|
Follicular helper cell (Tfh) activation, action
|
- Activated by - IL-6 from APC, IL-21 from other T-cell
- Action = helps B-cells in germinal centers to produce high-affinity antibody! |
|
Induced T-reg cells (iT-reg) activation, action)
|
- Activation = only see IL-2 and TGF-β from other T-cells
- Action = make IL-10, TGF-β, IL35 - Suppress immune response - Bad = can supress normal function too much... |
|
Th9 activation, action
|
- Activation by IL-4 and TGF-β
- Action - make IL-9 - Promotes mast cell activity like Th2 - Can produce inflammatory allergic responses |
|
Th1 inhibition actions
|
- Produces IFN-γ, negatively regulates Th2 and Th17
|
|
Th2 inhibition actions
|
- Produces IL-4, negatively regulates Th1 and Th17
|
|
T-reg and FoxP3+ cell inhibition actions
|
- Produce IL-10 and TGF-β
- Negatively regulate APC function, Th1 and Th2 |
|
5 Post-infection T-cell reducing agents
|
- CTLA-4
- Activation-induced Cell death (AICD) - Fas and TNF pathways - TGF-β (inhibit lymphocyte activation) - IL-10 (inhibit macrophage activation) - Regulatory T-cells - potent immunosuppressive action |
|
CTLA-4 on all active T-cells
|
- stimulates Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM)
- Binds B7, directly competes with CD28 - Turns off CD28 stimulation, can halt attack by T-cell |
|
Activation induced cell death (AICD) - via Fas
|
- If too many T-cells in crowded area
- Tend up upregulate FasL - Basically induce apoptosis in eachother |
|
T-reg cells
|
- Express FoxP3 - unique to T-reg cells
- 5-10% of peripheral CD4 cells - Immunosuppressive - make IL-10, TGF-β, IL-35 |
|
IPEX syndrome
|
- Lack of T-reg cells (mutations in FoxP3)
- Fatal autoimmune disease - X-linked |
|
Clinical applications of T-reg manipulation
|
- Enhancing/decreasing response for autoimmune disorders or cancers
|
|
Cyclosporin A (CsA)
|
- Inhibits T-cell activation
- Causes reduced production of IL-2 |
|
T-cell activation in absence of Csa
|
- Signals to T-cell activate NFAT
- NFAT goes to nucleus, upregulates IL-2 - More IL-2 -> more T-cell activation |
|
CsA inhibition mechanism
|
- NFAT can't get phosphorylated
- Can't upregulate IL-2 |
|
Protective immunity
|
- Requires memory T-cells and B-cells
- Allows faster response than activating all-new naive cells |